Dynamics of a virological model for cancer therapy with innate immune response (Q2210257): Difference between revisions

From MaRDI portal
Import240304020342 (talk | contribs)
Set profile property.
ReferenceBot (talk | contribs)
Changed an Item
 
(One intermediate revision by one other user not shown)
Property / full work available at URL
 
Property / full work available at URL: https://doi.org/10.1155/2020/8694821 / rank
 
Normal rank
Property / OpenAlex ID
 
Property / OpenAlex ID: W3089027679 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Analysis of virotherapy in solid tumor invasion / rank
 
Normal rank
Property / cites work
 
Property / cites work: The role of the innate immune system in oncolytic virotherapy / rank
 
Normal rank
Property / cites work
 
Property / cites work: Hopf bifurcation analysis and optimal control of treatment in a delayed oncolytic virus dynamics / rank
 
Normal rank
Property / cites work
 
Property / cites work: Introduction to functional differential equations / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q3989350 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Q4141027 / rank
 
Normal rank
Property / cites work
 
Property / cites work: Geometric Stability Switch Criteria in Delay Differential Systems with Delay Dependent Parameters / rank
 
Normal rank

Latest revision as of 23:30, 23 July 2024

scientific article
Language Label Description Also known as
English
Dynamics of a virological model for cancer therapy with innate immune response
scientific article

    Statements

    Dynamics of a virological model for cancer therapy with innate immune response (English)
    0 references
    0 references
    0 references
    0 references
    0 references
    5 November 2020
    0 references
    Summary: The aim of this work is to present a virological model for cancer therapy that includes the innate immune response and saturation effect. The presented model combines both the evolution of a logistic growing tumor and time delay which stands for the period of the viral lytic cycle. We use the delay differential equation in order to model this time which also means the time needed for the infected tumor cells to produce new virions after viral entry. We show that the delayed model has four equilibria which are the desired outcome therapy equilibrium, the complete failure therapy equilibrium, the partial success therapy free-immune equilibrium when the innate immune response has not been established, and the partial success therapy equilibrium with immune response. Furthermore, the stability analysis of equilibria and the Hopf bifurcation are properly exhibited.
    0 references

    Identifiers